scispace - formally typeset
B

Buddhi Tilakaratne

Researcher at Texas Center for Superconductivity

Publications -  13
Citations -  341

Buddhi Tilakaratne is an academic researcher from Texas Center for Superconductivity. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 8 publications receiving 81 citations.

Papers
More filters
Journal ArticleDOI

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021

TL;DR: The highest impact of booster doses against infection and death compared with full vaccination without booster doses was recorded among persons aged 50-64 and ≥65 years, and eligibility to stay up to date with COVID-19 vaccinations.
Journal ArticleDOI

Self-Assembled Gold Nano-Ripple Formation by Gas Cluster Ion Beam Bombardment

TL;DR: Rutherford backscattering spectrometry analysis reveals a formation of a surface gradient due to prolonged gas cluster ion bombardment, although the surface roughness remains consistent throughout the bombarded surface area.
Journal ArticleDOI

Cluster beams, nano-ripples, and bio applications

TL;DR: In this article, a review of ripple formation by gas cluster ions is discussed with respect to their formation mechanism, characteristics, and applications as biosensors, where the impact process of gas cluster ion is different from those of a collision cascade process induced by a single atomic or molecular (monomer) ion.
Journal ArticleDOI

Evolution of nanoripples on silicon by gas cluster-ion irradiation

TL;DR: In this article, a simple scaling functional satisfactorily describes the roughness and wavelength of the ripple patterns as a function of dosage and angle of incidence, and the ripples are formed orthogonal to the incident cluster-ions at large off-normal angles.
Journal ArticleDOI

COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022

TL;DR: In this article , the authors compared the impact of original (monovalent) COVID-19 vaccines and bivalent boosters and found that those who had received a bivalent booster received during the preceding 2 weeks-2 months improved protection against death.